Trichoblastic carcinoma ('malignant trichoblastoma') with lymphatic and hematogenous metastases

Modern Pathology

Volumn 13, Issue 6, 2000, Pages 673-678

  Regauer, Sigrid ^a,c   Beham Schmid, Christine ^a   Okcu, Murat ^a   Hartner, Edith ^b   Mannweiler, Sebastian ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b Internal Medicine Oncology   (Austria)

^c UNIVERSITY OF GRAZ   (Austria)

Author keywords

Cytokeratin; Hair appendage tumor; Hair keratin; Malignant transformation; Trichobiastic carcinoma; Trichoblastoma

Indexed keywords

ANTIBODY; CYTOKERATIN; GLYCOPROTEIN; PROTEIN BCL 2; PROTEIN P53; PROTEIN S 100;

ADULT; ARTICLE; B CELL LEUKEMIA; BASAL CELL; CANCER RECURRENCE; CASE REPORT; CELL DIFFERENTIATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CANCER; SKIN TUMOR; SPINDLE CELL; TRICHOBLASTIC CARCINOMA; TRICHOBLASTOMA;

EID: 0033917888     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880118     Document Type: Article

References (20)

1. Headington JT. Tumors of hair follicle: a review. Am J Pathol 1976;85:480-505.
2. Ackerman AB, Viragh PA, Chongchitnant N. Neoplasms with follicular differentiation. Ackerman's histologic diagnosis of neoplastic skin diseases: a method by pattern analysis. Philadelphia: Lea & Febiger; 1993.
3. Requena L, Barat A. Giant trichoblastoma on the scalp. Am J Dermatopathol 1993;15:497-502.
4. Santa Cruz DJ, Barr RJ, Headington JT. Cutaneous lymphadenoma. Am J Surg Pathol 1991;15:101-10.
5. Aloi F, Tomasini C, Pippione M. Pigmented trichoblastoma. Am J Dermatopathol 1992;14:345-9.
6. Akasaka T, Imamura Y, Mori Y, Iwasaki M, Kon S. Trichoblastoma with rippled-pattern. J Dermatol 1997;24:174-8.
7. Chan JK, Ng CS, Tsang WY. Nodular desmoplastic variant of trichoblastoma. Am J Surg Pathol 1994;18:495-500.
8. Heid HW, Moll I, Franke WW. Patterns of expression of trichogenic and epithelial cytokeratins in mammalian tissues: I. Human and bovine hair follicles. Differentiation 1988;37:137-57.
9. Schirren CG, Rütten A, Kaudewitz P, Diaz C, McClain S, Burgdorf WH. Trichoblastoma and basal cell carcinoma are neoplasms with follicular differentiation sharing the same profile of cytokeratin intermediate filaments. Am J Dermatopathol 1997;19:341-50.
10. Hunt SJ, Abell E. Malignant hair matrix tumor ("malignant trichoepithelioma") arising in the setting of multiple hereditary trichoepithelioma. Am J Dermatopathol 1991;13:275-81.
11. Sau P, Lupton GP, Graham JH. Trichogerminoma: a report of 14 cases. J Cutan Pathol 1992;19:357-65.
12. Sau P, Lupton GP, Graham JH. Pilomatrix carcinoma. Cancer 1993;71:2491-8.
13. Bartik MM, Welker D, Kay NE. Impairment in immune cell function in B-cell chronic lymphocytic leukemia. Semin Oncol 1998;25(1):27-33.
14. Hall P, Rosendahl I, Mattsson A, Einhorn S. Non-Hodgkin's lymphoma and skin malignancies - shared etiology? Int J Cancer 1995;62:519-22.
15. Levi F, Randimbison L, Te VC, La-Vecchia C. Non-Hodgkin's lymphoma, chronic lymphocytic leukemias and skin cancers. Br J Cancer 1996;74:1847-50.
16. Hartley BE, Searle AE, Breach NM, Rhys-Evans PH, Henk JM. Aggressive cutaneous squamous cell carcinoma of the head and neck in patients with chronic lymphocytic leukaemia. J Laryngol Otol 1996;110:694-5.
17. Davidovitz Y, Ballin A, Meytes D. Flare-up of squamous cell carcinoma of the skin following fludarabine therapy for chronic lymphocytic leukemia. Acta Hematol 1997;98:44-6.
18. Ohsawa M, Hashimoto M, Yasunaga Y, Shingu N, Aozasa K. Characteristics of non-Hodgkin's lymphoma complicated by renal cell malignancies. Oncology 1998;55:482-6.
19. Tanaka H, Tsukuma H, Teshima H, Ajiki W, Koyama Y, Kinoshita N, et al. Second primary cancers following non-Hodgkin's lymphoma in Japan: increased risk of hepatocellular carcinoma. Japan J Cancer Res 1997;88:537-42.
20. Martinez A, Miguel JFS, Valverde B, Barez A, J Moro M, Garcia-Marcos MA, et al. Functional expression of MDR-1 in acute myeloid leukemia: correlation with the clinical-biological, immunophenotypical and prognostic disease characteristics. Ann Hematol 1997;75:81-6.